Clinical Trials Browser

Completed × Neoplasms × pazopanib × Clear all

NCT02009449 2024-11-15

IVY

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT01468922 2022-07-01

Pazopanib and ARQ 197 for Advanced Solid Tumors

Phase 1 Completed

32 enrolled 21 charts

Neoplasms, Sarcoma

NCT01636908 2021-04-15

ICK

Phase NA Completed

Neoplasms

NCT01235962 2020-11-23

PROTECT

Phase 3 Completed

1,538 enrolled 27 charts

Carcinoma, Renal Cell, Neoplasms

NCT02138526 2020-10-19

DIET

Phase 1 Completed

Neoplasms

NCT01466972 2020-07-08

Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib

Phase 2 Completed

30 enrolled 11 charts

Breast Neoplasms, Neoplasms

NCT00674024 2019-11-20

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Phase 1 Completed

Lymphoma, Neoplasms

NCT00387205 2019-03-06

Study To Assess Long Term Safety Of Pazopanib

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT00861029 2017-11-14

VEG111485: A QTc Study of Pazopanib

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT00516672 2017-11-13

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Phase 1 Completed

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT00992121 2017-11-13

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms

NCT01108055 2017-06-09

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

Phase 2 Completed

43 enrolled 16 charts

Urinary Bladder Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Carcinoma, Renal Cell, Neoplasms, Patient Preference

NCT01262014 2016-08-11

Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer

Phase 2 Completed

Neoplasms

NCT00430781 2015-05-08

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Phase 2 Completed

228 enrolled 21 charts

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT01205230 2012-05-22

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK

Phase 4 Completed

34 enrolled 17 charts

Neoplasms

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Phase 2 Completed

12 enrolled 6 charts

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases